KR100569858B1 - 경피투여용 항구토제 조성물 - Google Patents
경피투여용 항구토제 조성물 Download PDFInfo
- Publication number
- KR100569858B1 KR100569858B1 KR1020030082322A KR20030082322A KR100569858B1 KR 100569858 B1 KR100569858 B1 KR 100569858B1 KR 1020030082322 A KR1020030082322 A KR 1020030082322A KR 20030082322 A KR20030082322 A KR 20030082322A KR 100569858 B1 KR100569858 B1 KR 100569858B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- transdermal administration
- skin
- weight
- epidermal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (12)
- 에탄올과 프로필렌글리콜의 혼합용매, 및 지방산 에스테르와 아마이드 화합물로 구성되는 피부투과촉진제로 이루어지는 경피투여용 기제; 그리고 항구토제 약물로서 트로피세트론이 함유된 경피투여용 항구토제 조성물에 있어서,에탄올과 프로필렌글리콜의 혼합용매 25 ~ 45 중량%, 지방산 에스테르 1.0 ~ 1.5 중량%와 아마이드 화합물 2 ~ 5 중량%로 구성되는 피부투과촉진제 및 pH 9 ~ 11의 붕산 완충용액 50 ~ 70 중량%로 이루어지는 경피투여용 기제; 그리고,상기 경피투여용 기제 100 중량%에 대해 항구토제 약물로서 트로피세트론 염산염 2.5 ~ 4 중량% 함유하며, pH 8 ~ 9 범위인 것을 특징으로 하는 경피투여용 항구토제 조성물.
- 제 1 항에 있어서, 상기 경피투여용 항구토제 조성물의 pH가 8.0 ∼ 8.5 범위인 것을 특징으로 하는 경피투여용 항구토제 조성물.
- 삭제
- 제 1 항에 있어서, 상기 트로피세트론 함유량은 2.5 ∼ 3.5 중량%인 것을 특징으로 하는 경피투여용 항구토제 조성물.
- 삭제
- 제 1 항에 있어서, 상기 지방산 에스테르는 글리세롤 모노라우레이트, 글리세롤 모노올레이트, 글리세롤 모노리놀레이트, 글리세롤 트리라우레이트, 글리세롤 트리올레이트, 글리세롤 트리카프릴레이트, 프로필렌글리콜 모노라우레이트, 프로필렌글리콜 디라우레이트, 카프릴릭/카프릭 트리글리세라이드, 메틸 라우레이트, 메틸 카프레이트, 이소프로필 미리스테이트, 이소프로필 팔미테이트, 에틸 올레이트 및 올레일 올레이트로 구성되는 그룹에서 선택된 어느 하나 또는 2 이상인 것을 특징으로 하는 경피투여용 항구토제 조성물.
- 제 6 항에 있어서, 상기 지방산 에스테르는 글리세롤 모노라우레이트인 것을 특징으로 하는 경피투여용 항구토제 조성물.
- 제 1 항에 있어서, 상기 아마이드 화합물은 N,N-디에틸-m-톨루아마이드, 라 우릭에시드 디에탄올아마이드, 우레아, 디메틸포름아마이드 및 디메틸아세트아마이드로 구성되는 그룹에서 선택된 어느 하나 또는 2 이상인 것을 특징으로 하는 경피투여용 항구토제 조성물.
- 제 8 항에 있어서, 상기 아마이드 화합물은 N,N-디에틸-m-톨루아마이드인 것을 특징으로 하는 경피투여용 항구토제 조성물.
- 삭제
- 제 1 항에 있어서, 상기 항구토제 조성물에 추가적으로 점증제를 경피투여용 기제 100 중량%에 대해 4 ∼ 5 중량% 첨가하는 것을 특징으로 하는 경피투여용 항구토제 조성물.
- 제 11 항에 있어서, 상기 점증제는 분자량이 800,000 ∼ 1,000,000인 하이드 록시프로필 셀룰로스인 것을 특징으로 하는 경피투여용 항구토제 조성물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020020079659 | 2002-12-13 | ||
KR20020079659 | 2002-12-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040053777A KR20040053777A (ko) | 2004-06-24 |
KR100569858B1 true KR100569858B1 (ko) | 2006-04-11 |
Family
ID=32588788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030082322A KR100569858B1 (ko) | 2002-12-13 | 2003-11-19 | 경피투여용 항구토제 조성물 |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR100569858B1 (ko) |
AU (1) | AU2003279578A1 (ko) |
WO (1) | WO2004054552A1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4054549A4 (en) | 2019-11-06 | 2023-12-06 | Smartech Topical, Inc. | TOPICAL FORMULATIONS OF CYCLO-OXYGENASE INHIBITORS AND THEIR USE |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000047208A1 (en) * | 1999-02-09 | 2000-08-17 | Samyang Corporation | A transdermal composition of an antivomiting agent and a preparation containing the same |
-
2003
- 2003-11-12 WO PCT/KR2003/002428 patent/WO2004054552A1/en not_active Application Discontinuation
- 2003-11-12 AU AU2003279578A patent/AU2003279578A1/en not_active Abandoned
- 2003-11-19 KR KR1020030082322A patent/KR100569858B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20040053777A (ko) | 2004-06-24 |
WO2004054552A1 (en) | 2004-07-01 |
AU2003279578A1 (en) | 2004-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2930623B2 (ja) | 医薬活性剤の経皮デリバリー用組成物 | |
CA2528360C (en) | Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine | |
KR20130112727A (ko) | 향진균성 약학적 조성물 | |
JP2006522154A (ja) | 動物用駆虫局所製剤 | |
KR100383252B1 (ko) | 부프레놀핀을함유하는경피투여조성물및이를포함하는패취 | |
CA2360300C (en) | A transdermal composition of an antivomiting agent and a preparation containing the same | |
CA2489188C (en) | Transdermal absorption preparation | |
EP0651993B1 (en) | Percutaneously administrable base composition and drug composition prepared therefrom | |
JPH03169812A (ja) | トリアセチンを含む活性持続性注射用処方剤 | |
CZ240297A3 (cs) | Transdermální přípravek | |
SK29195A3 (en) | An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxyethoxy)methyl|guanine (acyclovir) or salts or esters thereof | |
US7273619B2 (en) | Transdermal composition of an antivomiting agent | |
WO1995028914A1 (fr) | Composition de base administree par voie percutanee et composition medicamenteuse administree par voie percutanee obtenue a partir de cette derniere | |
TW202002977A (zh) | 治療搔癢症的組合物與方法 | |
KR100569858B1 (ko) | 경피투여용 항구토제 조성물 | |
US9254325B2 (en) | Percutaneously absorbed preparation | |
AU2020236525B2 (en) | Stable topical compositions of Fenoldopam | |
CA2038969A1 (en) | Compositions comprising cytotoxic agent and permeation enhancers | |
JPS59216818A (ja) | 経皮吸収外用製剤 | |
KR100390870B1 (ko) | 경피투여용 항구토제 조성물 및 이를 포함하는 제제 | |
KR100661871B1 (ko) | 속효성의 항진균 외용약제 조성물 | |
JPH10265379A (ja) | ドパミン誘導体含有経皮吸収型製剤 | |
JP2003160489A (ja) | オンダンセトロン経皮吸収用医薬組成物 | |
JP3050917B2 (ja) | 経皮投与基剤組成物とその薬剤組成物 | |
KR20220124891A (ko) | 나파모스타트 또는 이의 염을 포함하는 에멀젼을 포함하는 약제학적 제제 및 이의 제조 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130228 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140312 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150310 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160304 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170306 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180305 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190307 Year of fee payment: 14 |